CLARITY
Clarity Pharmaceuticals Ltd
| Research |
OneLook
Acronym Finder
|
| Serial Number | 98641763 |
| Mark Drawing Code | 4: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Janet W. Cho |
Timeline
| 2024-07-10 | Application Filed |
| 2024-07-10 | Location: |
| 2024-07-10 | Status: Live/Pending |
| 2024-07-10 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Clarity Pharmaceuticals Ltd |
| Entity Statement | 11 |
| Address | National Innovation Centre, 4 Cornwallis Eveleigh, NSW, AU 2015 |
| Legal Entity Type | |
| Legal Entity State | AU |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 6 |
| U.S. Codes: | 002,012,013,014,023,025,050 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 20 |
| U.S. Codes: | 002,013,022,025,032,050 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 39 |
| U.S. Codes: | 100,105 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0401 | Custom manufacture of pharmaceuticals; custom manufacture of pharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; custom manufacture of radiopharmaceuticals; custom manufacture of radiopharmaceuticals for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; custom manufacture of radioprotectors; custom manufacture of radiotherapy apparatus, devices and instruments; custom manufacture of apparatus, devices and instruments for medical purposes; custom manufacture of apparatus, devices and instruments for the treatment, imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; information, support, assistance, consultancy and advisory services in relation to the aforementioned services |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2024-07-10 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2024-07-10 | 2 NWOS I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 